BAT acquires stake in German cannabis company Sanity Group

Sep.27.2022
BAT acquires stake in German cannabis company Sanity Group
British American Tobacco acquires minority stake in German cannabis firm Sanity Group, continuing its exploration into non-nicotine areas.

BAT, through one of its wholly-owned subsidiaries, has acquired a non-controlling minority stake in Sanity Group, one of Germany's leading cannabis companies.


I'm sorry, but "Greenserenityca" does not make sense as a sentence or phrase in English, and therefore cannot be translated into standard journalistic English. Please provide a valid sentence or phrase to be translated.


This investment is a supplement to other recent investments made by BAT, the most notable being the strategic research and development partnership announced with Canada's Organigram Holdings in March of last year.


The Sanity Group, headquartered in Berlin, produces both consumer-focused CBD brands and medical cannabis brands, with a strong record of research, development, and marketing in the cannabis industry.


Kingsley Wheaton, the Chief Growth Officer of BAT, stated in a press release that the investment in Sanity Group is another example of BAT's exploration beyond nicotine and lays the foundation for BAT's future growth in various categories and regions.


We will continue to transform our business by better understanding our current and future consumers, which is part of our 'Better Tomorrow' objective.


Sanity, according to its founder and CEO Finn Age Hansel, has secured $37.6 million in funding during the second round of financing led by BAT. Approximately half of the funds will be allocated to strengthening Sanity's medical businesses while the remaining funds will be directed towards preparing for possible legalization of recreational marijuana in Germany.


Germany has not yet legalized recreational marijuana, but it is expected to do so sooner or later. Hansel stated that the German coalition government is "actively working" and "really hopes to develop a good draft law by the end of this year." "This is indeed a government priority.


This funding is an important milestone for us and a strong signal for the future of cannabis in Germany and Europe," said Max Narr, Chief Investment Officer of Sanity Group. "In the midst of a challenging global economy, we are proud to have secured such a significant amount of financing.


Statement:


This article is compiled from third-party information and is intended for industry-related communications and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS is unable to confirm the truthfulness and accuracy of the article's content. The compilation of this article is only intended for industry exchange and research.


Due to limitations in our translation abilities, the translated article may not fully express the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government concerning any domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and positions.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

KT&G to Cancel All 10.87 Million Treasury Shares on April 23
KT&G to Cancel All 10.87 Million Treasury Shares on April 23
KT&G disclosed on April 16 that it will cancel all 10.87 million treasury shares it currently holds, with the planned cancellation amounting to about KRW 1.85 trillion,(USD 1.26 billion). The cancellation date is scheduled for April 23.
Apr.17 by 2FIRSTS.ai
ITC Keeps Exclusion and Cease-and-Desist Orders in Place Against Stiiizy
ITC Keeps Exclusion and Cease-and-Desist Orders in Place Against Stiiizy
U.S. International Trade Commission has refused to pause the import and sales bans imposed on cannabis vape company Stiiizy while it appeals the agency’s patent infringement ruling in its dispute with Pax Labs.
Apr.07 by 2FIRSTS.ai
Exclusive | Shenzhen Tobacco Authorities Ask Licensed Chinese Vape Manufacturers to Submit STN Details for U.S.-Bound Products
Exclusive | Shenzhen Tobacco Authorities Ask Licensed Chinese Vape Manufacturers to Submit STN Details for U.S.-Bound Products
Shenzhen tobacco authorities have asked licensed Chinese vape manufacturers to submit STN details for U.S.-bound products, including CTP Portal or STN email screenshots, highlighting a new compliance signal in cross-border oversight.
Apr.02
Ukrainian Lawmaker Proposes Ban on Vapes, Heated Tobacco Devices and Hookahs for Under-17s
Ukrainian Lawmaker Proposes Ban on Vapes, Heated Tobacco Devices and Hookahs for Under-17s
Ukraine’s Verkhovna Rada has registered a bill that would ban the use of tobacco products, vapes, hookahs, herbal smoking mixtures and heated tobacco devices by people under 17. The bill was introduced by People’s Deputy Georgiy Mazurashu and has already been sent to the relevant parliamentary committee. The author said one reason for the initiative is the prevalence of vaping among adolescents.
Apr.28 by 2FIRSTS.ai
Smoore International Q1 Results: Enterprise-Focused Business Up 48.6% Year-on-Year, Proprietary E-Vapor Brand Business Up 14.3%
Smoore International Q1 Results: Enterprise-Focused Business Up 48.6% Year-on-Year, Proprietary E-Vapor Brand Business Up 14.3%
Smoore International reported its Q1 financial results, with revenue for the period reaching RMB3.856 billion, up 41.7% year-on-year, and net profit (profit for the period) totaling RMB262.5 million, up 36.6% year-on-year. Revenue from its enterprise-focused business was RMB3.2674 billion, representing a 48.6% increase from RMB2.1989 billion in the same period last year. Revenue from its proprietary brand business was RMB588.6 million, up 12.6% from RMB522.6 million a year earlier.
Apr.10 by 2FIRSTS.ai
Nature Health Comment Urges Wider Role for Smoke-Free Nicotine Products in Tobacco Control
Nature Health Comment Urges Wider Role for Smoke-Free Nicotine Products in Tobacco Control
Ahead of World No Tobacco Day, a Nature Health Comment by Robert Beaglehole, Ruth Bonita and Tikki Pang argues that regulated smoke-free nicotine products could help accelerate the global decline in smoking. The authors propose a “smoke-free 2040” goal and call for risk-proportionate regulation distinguishing cigarettes from lower-risk nicotine alternatives.
News
May.20